The State of Texas Attorney General Sues Tylenol Producers Regarding Autism Assertions
The top legal official in Texas Paxton is suing the manufacturers of acetaminophen, claiming the firms hid alleged dangers that the pain reliever created to children's brain development.
The lawsuit comes four weeks after Donald Trump promoted an unverified association between using Tylenol - referred to as acetaminophen - while pregnant and autism in young ones.
Paxton is taking legal action against the pharmaceutical giant, which once produced the drug, the only pain reliever recommended for pregnant women, and Kenvue, which currently produces it.
In a statement, he said they "betrayed America by gaining financially from discomfort and pushing pills ignoring the dangers."
The manufacturer states there is no credible evidence linking Tylenol to autism.
"These corporations misled for generations, intentionally threatening millions to line their pockets," the attorney general, from the Republican party, said.
Kenvue commented that it was "deeply concerned by the dissemination of inaccurate information on the safety of paracetamol and the potential impact that could have on the well-being of American women and children."
On its online platform, Kenvue also mentioned it had "consistently assessed the relevant science and there is insufficient valid information that demonstrates a established connection between consuming acetaminophen and autism."
Organizations acting on behalf of doctors and medical practitioners concur.
The leading OB-GYN organization has declared paracetamol - the main ingredient in Tylenol - is among limited choices for expectant mothers to manage discomfort and fever, which can present serious health risks if ignored.
"In over twenty years of investigation on the consumption of paracetamol in gestation, zero credible investigations has definitively established that the use of acetaminophen in any trimester of pregnancy results in brain development issues in children," the group stated.
The lawsuit references recent announcements from the Trump administration in claiming the medication is potentially dangerous.
Last month, the former president raised alarms from public health officials when he advised women during pregnancy to "fight like hell" not to take acetaminophen when sick.
The US Food and Drug Administration then published an announcement that medical professionals should contemplate reducing the consumption of Tylenol, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in young ones has remains unverified.
The Health Department head Kennedy, who supervises the Food and Drug Administration, had pledged in April to undertake "comprehensive study program" that would establish the source of autism in a limited time.
But specialists advised that discovering a sole reason of autism - thought by researchers to be the result of a complicated interplay of genetic and environmental factors - would be difficult.
Autism is a type of lifelong neurodivergence and disability that influences how persons encounter and engage with the world, and is diagnosed using doctors' observations.
In his lawsuit, the attorney general - who supports Trump who is seeking US Senate - asserts Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the science" around acetaminophen and autism spectrum disorder.
The lawsuit attempts to require the corporations "destroy any marketing or advertising" that claims Tylenol is reliable for pregnant women.
This legal action mirrors the concerns of a assembly of guardians of young ones with autism and ADHD who filed suit against the producers of acetaminophen in two years ago.
The court rejected the legal action, stating research from the parents' expert witnesses was not conclusive.